Biofrontera Press Release Reports Q2/H1 2025 Results with Non-GAAP Reconciliations

Rhea-AI Filing Summary

Biofrontera Inc. furnished a press release announcing its financial and operational results for the three and six months ended June 30, 2025. The press release is furnished as Exhibit 99.1 and the Company states it includes non-GAAP financial measures with quantitative reconciliations to the most directly comparable GAAP measures in accordance with Regulation G. The filing explicitly notes this information is being furnished rather than filed and therefore is not subject to Section 18 liability nor automatically incorporated by reference in registration statements. The Form 8-K also identifies the registrant as an emerging growth company and lists its registered securities, including common stock (BFRI) and warrants (BFRIW) traded on Nasdaq. This Form 8-K does not include numeric financial results; readers must refer to the attached press release for the detailed figures.

Positive

• Press release furnished reporting financial and operational results for the three- and six-month periods ended June 30, 2025
• Quantitative reconciliations provided linking non-GAAP measures to the most directly comparable GAAP measures in compliance with Regulation G
• Corporate disclosure identifies registered securities (common stock BFRI and warrants BFRIW) and emerging growth company status

Negative

• The Form 8-K does not include numeric financial results; detailed figures are contained only in the attached press release (Exhibit 99.1)
• Information is furnished, not filed, which limits Section 18 liability and means the content is not automatically incorporated by reference in registration statements

Insights

Financial Analyst

TL;DR: Routine earnings disclosure furnished with non-GAAP reconciliations; no numeric results are included in the 8-K itself.

The Company furnished a press release reporting results for the quarter and year-to-date period and provided Regulation G reconciliations for any non-GAAP measures. That practice supports transparency around non-GAAP metrics because the Company supplies quantitative reconciliations to GAAP. Because the information is furnished rather than filed, the Form 8-K limits Section 18 liability. The document lists registered securities including BFRI and BFRIW but contains no financial line items within the Form 8-K body.

Corporate Governance Expert

TL;DR: Disclosure is procedurally complete and compliant; material content is delivered via an attached press release rather than in-line within the Form 8-K.

The filing meets disclosure norms by furnishing the press release and noting the use of non-GAAP measures with reconciliations under Regulation G. It also clarifies the legal status of the disclosure by stating it is furnished, not filed, which is a standard governance and liability distinction. The Form identifies the company as an emerging growth company and lists its Nasdaq-registered securities. The 8-K itself does not present the underlying numeric results, so material financial detail must be reviewed in Exhibit 99.1.

false 0001858685 0001858685 2025-08-13 2025-08-13 0001858685 BFRI:CommonStockParvalue0001PerShareMember 2025-08-13 2025-08-13 0001858685 BFRI:PreferredStockPurchaseRightsMember 2025-08-13 2025-08-13 0001858685 BFRI:WarrantsToPurchaseCommonStockMember 2025-08-13 2025-08-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 13, 2025

Biofrontera Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-40943		47-3765675
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

120 Presidential Way, Suite 330 Woburn, Massachusetts		01801
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (781) 245-1325

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.001 per share		BFRI		The Nasdaq Stock Market LLC
Preferred Stock Purchase Rights		No		The Nasdaq Stock Market LLC
Warrants to purchase common stock		BFRIW		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (the “Exchange Act”) (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On August 13, 2025, Biofrontera Inc. (the “Company”) issued a press release announcing its financial and operational results for the three and six months ended June 30, 2025. A copy of the press release is being furnished as Exhibit 99.1 attached hereto to this Current Report on Form 8-K.

The Company’s press release contains non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with United States generally accepted accounting principles, or GAAP. Pursuant to the requirements of Regulation G, the Company has provided within the press release quantitative reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.

The information contained in this Item 2.02 in the Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall such information be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

99.1		Press Release Dated August 13, 2025
104		Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

August 13, 2025	Biofrontera Inc.
(Date)	(Registrant)
	/s/ E. Fred Leffler III
	E. Fred Leffler, III
	Chief Financial Officer

FAQ

What did Biofrontera (BFRI/BFRIW) disclose in this 8-K?

The company furnished a press release reporting financial and operational results for the three and six months ended June 30, 2025.

Is the detailed financial data included in the Form 8-K for BFRI?

No. The Form 8-K states numeric results are in the attached press release (Exhibit 99.1); the 8-K body does not present the financial figures.

Does the press release include non-GAAP measures for Biofrontera (BFRI)?

Yes. The press release contains non-GAAP financial measures and provides quantitative reconciliations to the most directly comparable GAAP measures under Regulation G.

What is the legal status of the information provided in this 8-K?

The information is furnished, not filed, and therefore is not subject to Section 18 liability or automatically incorporated by reference in registration statements.

Which securities of Biofrontera are listed in the filing?

The filing lists common stock (ticker BFRI) and warrants to purchase common stock (ticker BFRIW) as registered on The Nasdaq Stock Market.